Czeizel-Losonci syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2437OMIM:183802Q87.8
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Czeizel-Losonci syndrome is a very rare condition that affects the development of the limbs and urinary tract before birth. It is also sometimes referred to as ectrodactyly with urinary tract anomalies, or split hand/foot malformation with urinary tract defects. The syndrome is named after the researchers who first described it. Children born with this condition typically have abnormal hand or foot development — most notably a condition called ectrodactyly, where the middle fingers or toes are missing, giving the hand or foot a claw-like or split appearance. Along with these limb differences, affected individuals often have structural problems with the kidneys or other parts of the urinary system. Because this syndrome is so rare, the full range of symptoms and how they vary from person to person is not completely understood. Some individuals may have mild limb differences with minor kidney issues, while others may face more significant challenges. Treatment focuses on managing the specific problems each person has. Surgery may help improve hand and foot function, and kidney problems are monitored and treated by specialists. There is no cure, but with the right medical team, many aspects of the condition can be managed to improve quality of life.

Also known as:

Key symptoms:

Missing or fused middle fingers or toes (split hand or foot appearance)Claw-like or lobster-claw shape of the hands or feetKidney abnormalities present from birthProblems with the ureters (tubes connecting kidneys to the bladder)Bladder structural defectsAbnormal or absent fingers or toesPossible differences in the shape or size of the feetUrinary tract infections due to structural kidney problems

Clinical phenotype terms (34)— hover any for plain English
Split footHP:0001839Ureteral agenesisHP:0012300Posterolateral diaphragmatic herniaHP:0025193EctrodactylyHP:01002572-3 finger cutaneous syndactylyHP:0001233Hitchhiker thumbHP:0001234DextrocardiaHP:0001651MyelomeningoceleHP:0002475
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2024

HYMPAVZI: FDA approved

routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors, or hemophilia B (congenital factor IX deficiency) without factor IX inhibitors

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

HYMPAVZI

MARSTACIMAB-HNCQ· Pfizer Laboratories Div Pfizer IncOrphan Drug
routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without fact

routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency) without factor VIII inhibitors, or hemophilia B (congenital factor IX deficiency) without factor IX inhibitors

No actively recruiting trials found for Czeizel-Losonci syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Czeizel-Losonci syndrome community →

No specialists are currently listed for Czeizel-Losonci syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Czeizel-Losonci syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Czeizel-Losonci syndromeForum →

No community posts yet. Be the first to share your experience with Czeizel-Losonci syndrome.

Start the conversation →

Latest news about Czeizel-Losonci syndrome

No recent news articles for Czeizel-Losonci syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific kidney or urinary tract problems does my child have, and how serious are they?,Is genetic testing recommended for our family, and what gene should be tested?,What surgeries might help improve hand or foot function, and when should they happen?,How often should we monitor kidney function, and what signs should prompt an urgent visit?,What therapies are most important to start early for my child's development?,Are there other family members who should be evaluated or tested?,Are there any clinical trials or research studies we should know about?

Common questions about Czeizel-Losonci syndrome

What is Czeizel-Losonci syndrome?

Czeizel-Losonci syndrome is a very rare condition that affects the development of the limbs and urinary tract before birth. It is also sometimes referred to as ectrodactyly with urinary tract anomalies, or split hand/foot malformation with urinary tract defects. The syndrome is named after the researchers who first described it. Children born with this condition typically have abnormal hand or foot development — most notably a condition called ectrodactyly, where the middle fingers or toes are missing, giving the hand or foot a claw-like or split appearance. Along with these limb differences,

How is Czeizel-Losonci syndrome inherited?

Czeizel-Losonci syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Czeizel-Losonci syndrome typically begin?

Typical onset of Czeizel-Losonci syndrome is neonatal. Age of onset can vary across affected individuals.